...
首页> 外文期刊>Pharmaceutical statistics. >Adjusting for covariates in non-inferiority studies with margins defined as risk differences.
【24h】

Adjusting for covariates in non-inferiority studies with margins defined as risk differences.

机译:在非劣效性研究中调整协变量,其余量定义为风险差异。

获取原文
获取原文并翻译 | 示例
           

摘要

Adjusting for covariates makes efficient use of data and can improve the precision of study results or even reduce sample sizes. There is no easy way to adjust for covariates in a non-inferiority study for which the margin is defined as a risk difference. Adjustment is straightforward on the logit scale, but reviews of clinical studies suggest that the analysis is more often conducted on the more interpretable risk-difference scale. We examined four methods that allow for adjustment on the risk-difference scale: stratified analysis with Cochran-Mantel-Haenszel (CMH) weights, binomial regression with an identity link, the use of a Taylor approximation to convert results from the logit to the risk-difference scale and converting the risk-difference margin to the odds-ratio scale. These methods were compared using simulated data based on trials in HIV. We found that the CMH had the best trade-off between increased efficiency in the presence of predictive covariates and problems in analysis at extreme response rates. These results were shared with regulatory agencies in Europe and the USA, and the advice received is described.
机译:调整协变量可以有效利用数据,并且可以提高研究结果的准确性,甚至可以减少样本量。在非劣效性研究中,没有简单的方法可以调整协变量,其余量定义为风险差异。在logit量表上进行调整很简单,但是对临床研究的回顾表明,分析通常是在更具解释性的风险差异量表上进行的。我们研究了四种可在风险差异量表上进行调整的方法:使用Cochran-Mantel-Haenszel(CMH)权重进行分层分析,具有标识链接的二项式回归,使用泰勒近似法将结果从对数转换为风险-差异量表,并将风险差异裕度转换为优势比量表。使用基于艾滋病毒试验的模拟数据对这些方法进行了比较。我们发现CMH在存在预测协变量的情况下提高效率与在极端响应率下进行分析的问题之间具有最佳权衡。这些结果已与欧洲和美国的监管机构共享,并描述了收到的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号